Drug-induced thrombocytopenia.
D000368:Aged; D000372:Agglutination Tests; D000470:Alkaloids / Q000009:adverse effects; D000477:Alkylating Agents / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000937:Antigen-Antibody Reactions; D001379:Azathioprine / Q000009:adverse effects; D001772:Blood Cell Count; D001791:Blood Platelet Disorders / Q000175:diagnosis / Q000628:therapy; D001792:Blood Platelets / Q000187:drug effects*; D001853:Bone Marrow / Q000187:drug effects*; D001856:Bone Marrow Examination; D003018:Clot Retraction; D003168:Complement Fixation Tests; D003561:Cytarabine / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007231:Infant, Newborn; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects; D008875:Middle Aged; D011517:Prothrombin Time; D013921:Thrombocytopenia / Q000139:chemically induced*; D014149:Tranquilizing Agents / Q000009:adverse effects; D014747:Vinblastine / Q000009:adverse effects; D014750:Vincristine / Q000009:adverse effects
D000470:Alkaloids; D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D007004:Hypoglycemic Agents; D014149:Tranquilizing Agents; D003561:Cytarabine; D014750:Vincristine; D014747:Vinblastine; D015122:Mercaptopurine; D001379:Azathioprine; D005472:Fluorouracil